Detection of Cell Death in Tumors by Using MR Imaging and a Gadolinium-based Targeted Contrast Agent

Abstract

A relatively small (approximately 100 kDa) Gd(3+)-based contrast agent, which gives positive contrast on MR images, can be used to detect tumor cell death in vivo, and future derivatives of it may be used to assess early tumor responses to treatment.